Over 250 healthcare practitioners in the USA already recommending CuraLin to thousands of diabetic patients

CuraLife is pleased to announce the launch of a US-based clinical trial of 100 patients using CuraLin for blood sugar support. The study is being conducted in collaboration with the Washington Association of Naturopathic Physicians (WANP) and National University of Natural Medicine (NUNM).

With hundreds of healthcare practitioners already recommending CuraLin to thousands of patients, CuraLife continues expanding into the offline in-clinical channel, which is seeing a reawakening as COVID cases decline across the USA.

“This is an opportune time for clinical trials” says Remy Reinstein, US Sales Director at CuraLife. “We have seen very strong clinician response to CuraLin as we expand our network of healthcare providers and educational institutions, like our recent partnership with Bastyr University” he adds.

CuraLife is proud to continue partnering with leading doctors and educational institutions, together building the scientific foundation for CuraLin natural glucose support.
To see why more and more doctors are recommending CuraLin, visit www.curalife.com.